| Disclosure of analysis of single amount of discontinued operations [Table Text Block] |
| |
|
Six months
|
|
|
Three months
|
|
| |
|
|
|
|
|
|
|
Revenues
|
|
$
|
21,686
|
|
|
$
|
11,118
|
|
|
Cost of revenues
|
|
|
15,399
|
|
|
|
8,100
|
|
| |
|
|
|
|
|
|
|
|
|
Gross profit before fair value adjustments
|
|
|
6,287
|
|
|
|
3,018
|
|
| |
|
|
|
|
|
|
|
|
|
Fair value adjustments:
|
|
|
|
|
|
|
|
|
|
Unrealized change in fair value of biological assets
|
|
|
1,449
|
|
|
|
55
|
|
|
Realized fair value adjustments on inventory sold in the period
|
|
|
(1,757
|
)
|
|
|
(1,261
|
)
|
| |
|
|
|
|
|
|
|
|
|
Total fair value adjustments
|
|
|
(308
|
)
|
|
|
(1,206
|
)
|
| |
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
5,979
|
|
|
|
1,812
|
|
| |
|
|
|
|
|
|
|
|
|
General and administrative expenses
|
|
|
12,942
|
|
|
|
7,844
|
|
|
Selling and marketing expenses
|
|
|
3,164
|
|
|
|
1,905
|
|
|
Share-based compensation
|
|
|
816
|
|
|
|
316
|
|
|
Restructuring
|
|
|
4,779
|
|
|
|
4,779
|
|
| |
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
21,701
|
|
|
|
14,844
|
|
| |
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
(15,722
|
)
|
|
|
(13,032
|
)
|
| |
|
|
|
|
|
|
|
|
|
Finance expenses, net
|
|
|
(3,413
|
)
|
|
|
(2,416
|
)
|
| |
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(19,135
|
)
|
|
|
(15,448
|
)
|
|
Income tax expense (benefit)
|
|
|
(199
|
)
|
|
|
(171
|
)
|
| |
|
|
|
|
|
|
|
|
|
Net loss from discontinued operations, net of tax
|
|
$
|
(18,936
|
)
|
|
$
|
(15,277
|
)
|
|